Scilex Holding (SCLX) Treasury Shares (2022 - 2026)
Scilex Holding (SCLX) posted quarterly Treasury Shares of $76.9 million for Q1 2026, little changed year-over-year from $76.9 million in Q1 2025, and little changed quarter-over-quarter from $76.9 million in Q4 2025.
Scilex Holding (SCLX) Treasury Shares (2022 - 2026) Analysis & Trends
Scilex Holding's Treasury Shares history runs 4 years deep, the most recent figure standing at $76.9 million for Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $76.9 million; the TTM figure through Mar 2026 stood at $76.9 million (changed 0.0% YoY), while the FY2025 annual figure was $76.9 million, down 15.03% from the prior year.
- Treasury Shares for Q1 2026 stood at $76.9 million, roughly flat from $76.9 million in the prior quarter.
- The five-year high for Treasury Shares was $60.1 million in Q3 2023, with the low at $1458.0 in Q1 2025.
- The 5-year median for Treasury Shares is $3.2 million (2025), against an average of $21.1 million.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares changed 0.0% in 2024, then dropped 15.03% in 2025.
- Scilex Holding's Treasury Shares stood at $90.5 million in 2023, then changed by 0.0% to $90.5 million in 2024, then decreased by 15.03% to $76.9 million in 2025, then changed by 0.0% to $76.9 million in 2026.
- Business Quant data shows SCLX's Treasury Shares at $76.9 million in Q1 2026, $76.9 million in Q4 2025, and $76.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.01 Bn | 633.25 Bn | 17.26 Bn | 75.86 Bn |
| 2 | AbbVie | 469.88 Bn | 463.31 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 376.95 Bn | 369.81 Bn | 12.21 Bn | 1.11 Bn |
| 4 | Novartis Ag | 302.99 Bn | 295.30 Bn | 11.24 Bn | 49.00 Mn |
| 5 | Astrazeneca | 258.13 Bn | 253.23 Bn | 12.86 Bn | - |
| 6 | Amgen | 236.66 Bn | 222.67 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 183.33 Bn | 180.15 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.34 Bn | 148.64 Bn | 10.94 Bn | 115.19 Bn |
| 9 | Gsk | 106.10 Bn | 101.93 Bn | 8.24 Bn | - |
| 10 | Scilex Holding | 39.90 Mn | -72.88 Mn | 3.97 Mn | 3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.13 Mn |
| Mar 31, 2026 | 76.92 Mn |
| Mar 31, 2026 | 3.13 Mn |
| Mar 31, 2026 | 76.92 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Dec 31, 2025 | 76.92 Mn |
| Dec 31, 2025 | 76.92 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 76.92 Mn |
| Sep 30, 2025 | 76.92 Mn |
| Sep 30, 2025 | 3.37 Mn |
| Sep 30, 2025 | 3.37 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 76.92 Mn |
| Jun 30, 2025 | 76.92 Mn |
| Mar 31, 2025 | 76.92 Mn |
| Mar 31, 2025 | 1,458.00 |
| Mar 31, 2025 | 1,458.00 |
| Mar 31, 2025 | 76.92 Mn |